Researcher Profile

Researcher Profile

Marc Rovito, MD

Marc Rovito, MD

Assistant Professor, Department of Medicine
Division of Hematology and Oncology
Disease Teams:
Breast Cancer
Central Nervous System Cancer
General Care
Genitourinary Cancer
Gynecological Cancer
Head and Neck Cancer
Liver, Pancreas and Foregut Cancer
Melanoma and Skin Cancer
Thoracic Cancer
mar54@psu.edu

Research Interests

  • Therapeutics
  • Non-Small Cell Lung Carcinoma
  • Paclitaxel
  • Teaching
  • Cetuximab
  • Heart Atria
  • Bacteremia
  • Heart Neoplasms
  • Myxoma
  • Streptococcal Infections
  • Bacterial Endocarditis
  • Role Playing

Clinical Trials

MATCH Treatment Subprotocol C2: Crizotinib in Patients with Tumors with MET Exon 14 Deletion
MATCH Treatment Subprotocol E: AZD9291 in Patients with Tumors Having EGFR T790M Mutations (Except Non-Small Cell Lung Cancer) or Rare Activating Mutations of EGFR
MATCH Treatment Subprotocol F: Crizotinib in Patients with Tumors (Other Than Adenocarcinoma of Lung or ALCL) with ALK Rearrangements
MATCH Treatment Subprotocol G: Phase II Study of Crizotinib in Patients with ROS1 Translocations (Other Than Patients with Non-Small Cell Lung Cancer)
MATCH Treatment Subprotocol T: GDC-0449 (vismodegib) in Patients with Tumors (except basal cell skin carcinoma) with Smoothened (SMO) or Patched 1 (PTCH1) Mutations
MATCH Treatment Subprotocol V: Phase II Study of Sunitinib in Patients with Tumors with c-Kit Mutations (Excluding GIST, Renal Cell Carcinoma or Pancreatic Neuroendocrine Tumor).

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)